Evrofarma SA (EVROF) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Evrofarma SA (EVROF) has a cash flow conversion efficiency ratio of 0.108x as of December 2022. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€1.52 Million ≈ $1.77 Million USD) by net assets (€14.03 Million ≈ $16.40 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Evrofarma SA - Cash Flow Conversion Efficiency Trend (2014–2022)
This chart illustrates how Evrofarma SA's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Evrofarma SA (EVROF) total liabilities for a breakdown of total debt and financial obligations.
Evrofarma SA Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Evrofarma SA ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Kingston Resources Ltd
AU:KSN
|
0.081x |
|
Bright Sheland International Co Ltd
TWO:4556
|
0.038x |
|
Tanami Gold NL
AU:TAM
|
-0.106x |
|
Sensus Healthcare Inc
NASDAQ:SRTS
|
0.048x |
|
Arthavest Tbk
JK:ARTA
|
-0.005x |
|
Samhyun Steel Co. Ltd
KQ:017480
|
-0.022x |
|
YES24 Co.Ltd
KQ:053280
|
0.014x |
|
Hwacheon Mac
KO:000850
|
0.007x |
Annual Cash Flow Conversion Efficiency for Evrofarma SA (2014–2022)
The table below shows the annual cash flow conversion efficiency of Evrofarma SA from 2014 to 2022. For the full company profile with market capitalisation and key ratios, see Evrofarma SA market cap and net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2022-12-31 | €14.03 Million ≈ $16.40 Million |
€2.44 Million ≈ $2.85 Million |
0.174x | +372.38% |
| 2021-12-31 | €12.61 Million ≈ $14.74 Million |
€-805.00K ≈ $-941.13K |
-0.064x | -156.73% |
| 2020-12-31 | €12.95 Million ≈ $15.14 Million |
€1.46 Million ≈ $1.70 Million |
0.113x | -24.84% |
| 2019-12-31 | €11.87 Million ≈ $13.88 Million |
€1.78 Million ≈ $2.08 Million |
0.150x | -23.84% |
| 2018-12-31 | €11.65 Million ≈ $13.63 Million |
€2.29 Million ≈ $2.68 Million |
0.197x | -32.08% |
| 2017-12-31 | €10.73 Million ≈ $12.54 Million |
€3.11 Million ≈ $3.63 Million |
0.290x | +173.21% |
| 2016-12-31 | €10.20 Million ≈ $11.93 Million |
€1.08 Million ≈ $1.26 Million |
0.106x | -25.34% |
| 2015-12-31 | €9.79 Million ≈ $11.45 Million |
€1.39 Million ≈ $1.63 Million |
0.142x | +51.87% |
| 2014-12-31 | €9.27 Million ≈ $10.83 Million |
€866.00K ≈ $1.01 Million |
0.093x | -- |
About Evrofarma SA
Evrofarma SA produces and sells dairy products in Greece. It offers milk, yoghurt, and cheese products, as well as fermented beverages. The company also exports its products. Evrofarma SA was founded in 1991 and is headquartered in Didymoteicho, Greece.